Condition
Radiation Induced Xerostomia
Total Trials
2
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Sialendoscopy
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Phase 1 (1)
Trial Status
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT02446249Phase 1Completed
Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction
NCT07476209Not ApplicableRecruitingPrimary
Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia
Showing all 2 trials
Research Network
Common Treatments
- Sialendoscopy1
- Aav2haqp11
- Photobiomodulation1
Active Sponsors
- National Institute of Dental and Craniofacial Research (NIDCR)1
- Alexandria University1
- MeiraGTx, LLC1
Top Investigators
National Institute of Dental and Craniofacial Research (NIDCR)
Related Conditions
- Salivary Hypofunction1
- Squamous Cell Head And Neck Cancer1